Tirzepatide – Dual GIP and GLP-1 Research Peptide

Tirzepatide is an advanced synthetic peptide studied for its dual activity at the glucose-dependent insulinotropic polypeptide receptor, known as GIP, and the glucagon-like peptide-1 receptor, known as GLP-1. Its distinctive dual-receptor profile makes Tirzepatide particularly relevant for laboratory research involving incretin signalling, receptor pharmacology, metabolic pathways and long-acting peptide development. Tirzepatide is a modified 39-amino-acid peptide based on the natural GIP sequence. Its molecular structure contains a C20 fatty-diacid component that promotes albumin binding and supports an extended molecular profile.

Vigtige produktfunktioner

• Avanceret syntetisk forskningspeptid
• Dual GIP and GLP-1 receptor activity
• Modified 39-amino-acid peptide structure
• Langtidsvirkende lipideret molekylært design
• Relevant for incretin and metabolic pathway research
• Velegnet til receptorbindings- og signaleringsstudier
• Leveres som frysetørret forskningsmateriale
• Tydelige batchspecifikke produktoplysninger
• Sikker og diskret emballage
• Fast and trackable delivery

What Is Tirzepatide?

Tirzepatide is a synthetic peptide engineered to interact with both GIP and GLP-1 receptors. GIP and GLP-1 belong to the incretin hormone family and are widely studied for their involvement in nutrient-responsive signalling, pancreatic cell activity, glucose-dependent pathways and communication between the digestive system, pancreas and central nervous system. Unlike compounds that interact exclusively with the GLP-1 receptor, Tirzepatide combines activity at two incretin-related receptor systems. This makes it an important reference compound for researchers comparing single-receptor and dual-receptor signalling.

Dual-Receptor Research Profile

The dual GIP and GLP-1 receptor profile of Tirzepatide allows researchers to study how two related signalling pathways may interact within the same experimental model. Relevant areas of laboratory research include:

• GIP receptor activation
• GLP-1-receptoraktivering
• Dual-receptor pharmacology
• Receptor affinity and selectivity
• Intracellulær signaltransduktion
• Cyklisk AMP-signalering
• Receptorinternalisering
• Ligand-receptor interactions
• Concentration-response relationships
• Forudindtaget receptorsignalering
• Comparative incretin research
• Pankreascellesignalering
• Nutrient-responsive pathways
• Metabolic homeostasis
• Appetite-related neuroendocrine signalling

Avanceret molekylært design

Tirzepatide is based on the native GIP peptide sequence and contains several structural modifications designed to improve its molecular stability and duration. A C20 fatty-diacid component supports reversible albumin binding. Albumin-binding technology is an important research area in modern peptide development because it can reduce rapid molecular clearance and extend the period during which a peptide remains available for analysis. This specialised structure makes Tirzepatide relevant for research involving:

• Peptidlipidering
• Albumin-bindende mekanismer
• Molekylær stabilitet
• Enzymatisk resistens
• Udvidet peptideksponering
• Farmakokinetisk optimering
• Long-acting peptide engineering
• Structure-activity relationships
• Peptide formulation development

Potentielle forskningsanvendelser

Tirzepatide may be studied in controlled laboratory environments involving:

Incretin-Receptor Research

Researchers may compare the activation and downstream signalling of GIP and GLP-1 receptors in cellular or biochemical models.

Metabolic Signalling

Tirzepatide is relevant for studies examining how incretin-related receptor systems contribute to metabolic communication and nutrient-responsive signalling.

Glucose-Homeostasis Pathways

Laboratory research may examine receptor pathways associated with pancreatic signalling, glucose-dependent cellular responses and interactions between incretin hormones.

Neuroendocrine Research

GIP and GLP-1 receptors are studied in relation to communication between peripheral metabolic signals and regions of the central nervous system involved in energy balance and appetite-related signalling.

Long-Acting Peptide Development

The lipidated structure of Tirzepatide makes it useful for research into albumin binding, peptide stability and extended-duration molecular design.

Comparative Peptide Analysis

Researchers may compare Tirzepatide with native GIP, native GLP-1, selective GLP-1 receptor agonists or other multi-receptor peptide compounds.

Produktspecifikationer

Produktkarakteristik	Information
Produktnavn	Tirzepatide
Forskningsbetegnelse	Dual GIP and GLP-1 receptor agonist
Produktkategori	Syntetisk forskningspeptid
Peptide structure	Modified 39-amino-acid peptide
Reference sequence	Based on the natural GIP sequence
Molecular modification	Lipidated structure with a C20 fatty diacid
Primære forskningsmål	GIP and GLP-1 receptors
Form	Frysetørret pulver
Præsentation	Sealed research vial
Dokumentation	Batch-specific analytical documentation
Emballage	Sikker og diskret emballage
Tilsigtet anvendelse	Scientific and laboratory research

Frysetørret forskningsformat

Tirzepatide is supplied as a lyophilised research material in a sealed vial. Lyophilisation removes moisture from the material and is commonly used to support stability during controlled storage and transportation. The physical appearance of the product may vary slightly depending on quantity, production conditions and residual moisture. Product identity and quality should be assessed using the applicable batch information rather than physical appearance alone.

Quality and Transparency

Peptides Divas focuses on clear product information, batch-level traceability and professional presentation. Depending on the applicable batch, product documentation may contain:

• Produktidentifikation
• Batch- eller lotnummer
• Rapporteret renhed
• HPLC-analyse
• Mass spectrometry data
• Testoplysninger
• Storage guidance
• Additional analytical observations

This allows researchers to review the available specifications before beginning laboratory analysis.

Opbevaringsoplysninger

Store the sealed Tirzepatide vial under the conditions stated on the product label and applicable batch documentation. Protect the research material from:

• Direkte sollys
• Overdreven varme
• Fugtighed
• Forurening
• Gentagne temperaturudsving
• Unødvendig eksponering for luft

The receiving laboratory is responsible for establishing suitable preparation, handling and storage procedures for its specific experimental protocol.

Why Choose Tirzepatide?

Tirzepatide offers a distinctive dual-receptor profile within one advanced peptide structure. Key research advantages include:

• Combined GIP and GLP-1 receptor activity
• Specialised long-acting molecular design
• Relevance for modern incretin research
• Suitable for comparative receptor studies
• Valuable for metabolic signalling research
• Relevant for peptide-engineering studies
• Convenient lyophilised format
• Batchspecifikke analytiske oplysninger

Hvorfor bestille fra Peptides Divas?

Peptides Divas combines a carefully selected research catalogue with professional service and reliable order processing. Customers benefit from:

• Clear product specifications
• Batch-specific documentation
• Hurtig ordrebehandling
• Sikker og diskret emballage
• Sporbare forsendelsesmuligheder
• Responsive customer service
• Carefully handled research products
• Convenient European delivery

Choose Tirzepatide from Peptides Divas for advanced laboratory research involving dual GIP and GLP-1 receptor signalling, incretin pathways and long-acting peptide development.